Evidence map›Paper›PMID 25339832›Full record

ArticleWorld journal of gastroenterology2014

Liver resection and metabolic disorders: an undescribed mechanism leading to postoperative mortality.

Alban Zarzavadjian Le Bian, Renato Costi, Mohamed Said Sbai-Idrissi, Claude Smadja

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alban Zarzavadjian Le BianAlban Zarzavadjian Le Bian, Renato Costi, Claude Smadja, Service de Chirurgie Digestive, Hôpital Antoine Béclère, Clamart, Assistance Publique-Hôpitaux de Paris, Université Paris Sud-XI, 91400 Orsay, France.
Renato CostiAlban Zarzavadjian Le Bian, Renato Costi, Claude Smadja, Service de Chirurgie Digestive, Hôpital Antoine Béclère, Clamart, Assistance Publique-Hôpitaux de Paris, Université Paris Sud-XI, 91400 Orsay, France.
Mohamed Said Sbai-IdrissiAlban Zarzavadjian Le Bian, Renato Costi, Claude Smadja, Service de Chirurgie Digestive, Hôpital Antoine Béclère, Clamart, Assistance Publique-Hôpitaux de Paris, Université Paris Sud-XI, 91400 Orsay, France.
Claude SmadjaAlban Zarzavadjian Le Bian, Renato Costi, Claude Smadja, Service de Chirurgie Digestive, Hôpital Antoine Béclère, Clamart, Assistance Publique-Hôpitaux de Paris, Université Paris Sud-XI, 91400 Orsay, France.
Université Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the mechanism leading to perioperative mortality in patients undergoing major liver resection and presenting with metabolic disorders.

methodsThe link between Metabolic Syndrome and non-alcoholic fatty liver disease is currently demonstrated. Various metabolic disorders and the Metabolic Syndrome (the association of ≥ 3 metabolic disorders) have been recently described as a risk factor of perioperative mortality in major liver resection. Patients who passed away during perioperative course of major liver resection and presenting with the association of ≥ 2 metabolic disorders without any other known cause of liver disorders were reviewed.

resultsFrom January 2001 to May 2010 in a tertiary centre, ten patients presenting with ≥ 2 metabolic disorders without any other known cause of liver disorders died during perioperative course of major liver resection. The same four-consecutive-steps sequence of events occurred, including jaundice. The analysis of this series suggested a rapidly deteriorating congestive liver resulting in an increased portal hypertension leading to hepatorenal syndrome and lately to multiorgan failure (mimicking septic collapse) as the mechanism leading to exitus. The acute portal hypertension is mainly related to the surgical procedure. The chronic portal hypertension is indeterminate. Patients with ≥ 2 metabolic disorders should be considered as potentially presenting with portal hypertension possibly evolving towards hepatorenal syndrome; thus, they should be considered as having a high perioperative risk and should be carefully evaluated before undergoing major liver resection.

conclusionAs fibrosis was not present or marginal in liver specimens, the real cause of portal hypertension in patients with multiple metabolic disorders should be investigated with further studies.

Indexed as

AgedFemaleFranceHepatectomyHepatorenal SyndromeHospital MortalityHumansHypertension, PortalLiver NeoplasmsMaleMetabolic DiseasesMiddle AgedMultiple Organ FailurePatient SelectionRetrospective StudiesRisk AssessmentHepatorenal syndromeLiver resectionMajor hepatectomyMetabolic syndromePostoperative mortality

Identifiers

PMID25339832
PMCPMC4202374
OpenAlexW1631917893

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.